title: Combined administration of Fasudil hydrochloride and nitroglycerin for treatment of cerebral vasospasm.
authors.affiliation: Department of Surgical Neurology, Jichi Medical School, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: T
authors.initials: T
authors.lastname: Masuzawa
authors.forename: M
authors.initials: M
authors.lastname: Saito
authors.forename: T
authors.initials: T
authors.lastname: Yamada
authors.forename: A
authors.initials: A
authors.lastname: Ebihara
authors.forename: H
authors.initials: H
authors.lastname: Iwasa
authors.forename: S
authors.initials: S
authors.lastname: Mori
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000368:Aged; D002545:Brain Ischemia / Q000453:epidemiology / Q000209:etiology; D004338:Drug Combinations; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000453:epidemiology / Q000209:etiology; D005996:Nitroglycerin / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020301:Vasospasm, Intracranial / Q000150:complications / Q000188:drug therapy*
chemical_list: D004338:Drug Combinations; D014665:Vasodilator Agents; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D005996:Nitroglycerin; C049347:fasudil